Targeted CD22/CD19 CAR-T Therapy for Consolidation in Standard-Risk B-ALL

Clinical trial NCT07575919 · RECRUITING

Trial details

NCT number: NCT07575919
Sponsor: Liping Dou
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia

Start date: 2026-01-01
Primary completion: 2026-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.